Cheville N F, Olsen S C, Jensen A E, Stevens M G, Florance A M, Houng H S, Drazek E S, Warren R L, Hadfield T L, Hoover D L
National Animal Disease Center, U.S. Department of Agriculture, Ames, Iowa 50010, USA.
Infect Immun. 1996 Jul;64(7):2431-9. doi: 10.1128/iai.64.7.2431-2439.1996.
To evaluate host responses, young goats were inoculated subcutaneously with a genetic deletion mutant (deltapurE201) of Brucella melitensis (n = 6), its virulent parental strain 16M (n = 6), or saline (n = 6). No clinical evidence of brucellosis was seen in any goat. Serum antibody titers peaked at postinoculation day (PID) 14. Bacteria in lymph nodes that drained sites of vaccination reached peak numbers of >10(6) CFU/g in both infected groups at PID 7 and progressively declined to PID 84. At necropsy, bacteria were present in mammary lymph nodes or spleen of 33% of goats given virulent 16M but in none of goats given the purE mutant. Lymphadenitis, most severe in goats given 16M, involved depletion of lymphocytes and germinal centers, proliferation of lymphoblasts, and vasculitis. By PID 28, lymph node architecture was restored; there was marked germinal center formation and medullary plasmacytosis. Brucellar antigens, detected with immunoperoxidase techniques, were prominent in capsular granulomas but not in lymph node cortices. Ultrastructurally, bacteria were found in macrophages (>97%) and small lymphocytes (<3%) but not in large lymphocytes. Bacteria were intact in small lymphocytes but in macrophages were in various stages of degradation. The deltapurE phenotype of deltapurE201 was preserved during infection of goat lymph nodes. Unlike Salmonella spp. purE mutants, strain deltapurE201 may be a candidate for efficacy testing; it produced immune responses, was cleared from visceral tissues, and produced less severe pathologic changes than its wild-type parent.
为评估宿主反应,将幼年山羊皮下接种羊种布鲁氏菌的基因缺失突变体(deltapurE201)(n = 6)、其强毒株亲本菌株16M(n = 6)或生理盐水(n = 6)。所有山羊均未出现布鲁氏菌病的临床证据。血清抗体滴度在接种后第14天达到峰值。在接种后第7天,两个感染组中引流接种部位的淋巴结中的细菌数量均达到>10(6) CFU/g的峰值,并在接种后第84天逐渐下降。尸检时,接种强毒株16M的山羊中有33%的乳腺淋巴结或脾脏中存在细菌,而接种purE突变体的山羊中均未发现。淋巴结炎在接种16M的山羊中最为严重,包括淋巴细胞和生发中心的耗竭、成淋巴细胞增殖和血管炎。到接种后第28天,淋巴结结构恢复;有明显的生发中心形成和髓质浆细胞增多。用免疫过氧化物酶技术检测到的布鲁氏菌抗原在包膜肉芽肿中突出,但在淋巴结皮质中不突出。超微结构观察发现,细菌存在于巨噬细胞(>97%)和小淋巴细胞(<3%)中,但不存在于大淋巴细胞中。细菌在小淋巴细胞中完整,但在巨噬细胞中处于不同的降解阶段。deltapurE201的deltapurE表型在山羊淋巴结感染过程中得以保留。与沙门氏菌属的purE突变体不同,菌株deltapurE201可能是疗效测试的候选菌株;它产生免疫反应,从内脏组织中清除,并且产生的病理变化比其野生型亲本轻。